Open Text Corporation

Open Text Corporation

September 06, 2005 09:25 ET

MerseyBIO Chooses Open Text's Livelink ECM for Bio Tech Network

LONDON, UNITED KINGDOM--(CCNMatthews - Sept. 2, 2005) -

Solution Saves Time, Enhances Performance of Life Sciences Sector

Open Text™ Corporation (NASDAQ:OTEX)(TSX:OTC), the leading independent provider of Enterprise Content Management (ECM) software, said today that MerseyBIO has adopted Open Text's Livelink ECM software to improve processes, strategic planning and collaboration between biotechnology companies, investors and public bodies in the UK.

MerseyBIO, based at the University of Liverpool, UK, supports the development of local life-sciences start-ups and raises the profile of Liverpool as a leading life sciences location. MerseyBIO ( provides laboratory and associated office space for up to 15 biotechnology companies, and provides in-house business consulting and support services.

For the first time in the UK, small biotechnology companies and other MerseyBIO members can manage information and processes, and share knowledge online to accelerate research and business development. The system, called esymbio™, streamlines internal processes to improve business planning, research coordination and the management of projects such as grant applications and requests for proposals. Livelink ECM also helps to deliver dynamic collaboration and knowledge sharing between individuals, teams and organizations.

The system's built-in access privileges enhance personalized information, cross-disciplinary collaboration, and rapid identification of appropriate partners to complete projects and service information needs. This reduces online research time and improves communications between members.

Dr. Geoff Wainwright, MerseyBio Incubator Manager said: "esymbio supports the development of an innovative and growing biotechnology sector - it's almost like a primary meeting point for the great and the good in regional biotechnology. Open Text's Livelink ECM plays a key role in enabling us to use esymbio to support medical and biotech development."

Professor David Hornby, Chief Executive of Combigen Limited said: "esymbio is particularly important in the development of life-changing pharmaceutical products, where close co-operation amongst researchers, commercial organizations and public institutions is vital to success. Livelink ECM has enabled esymbio to bring these different groups together for the first time, encouraging an active exchange of data, ideas, knowledge and experiences."

Damian Hyland, Vice President of Northern Europe at Open Text, said: "This is a perfect example of how Livelink ECM brings people, processes and information together to solve business problems. MerseyBIO's esymbio is unique in the way it allows members to identify new partnerships, and develop new project areas by quickly making available the latest information on critical issues in biotechnology."

About MerseyBio

MerseyBIO, a specialist business support unit based in the University of Liverpool, is leading the development of the life sciences sector on Merseyside through start-up and incubation, assisting local life sciences businesses and raising the profile of Liverpool as a leading UK life sciences location. MerseyBIO ( is located in the state-of-the-art Business Incubator Building, a facility that provides laboratory and associated office space for up to 15 biotechnology companies as well as providing in-house specialist support to help young biotechnology companies through the difficult early days. Recently, a MerseyBIO-based company, Provexis, was the first incubator company to list on the AIM stock exchange.

About Open Text

Open Text™ is the leading independent provider of Enterprise Content Management (ECM) solutions that bring together people, processes and information in global organizations. Today, the company supports almost 20 million seats across 13,000 deployments in 114 countries and 12 languages worldwide. For more information on Open Text, go to:

This news release may contain forward-looking statements relating to the success of any of the Company's strategic initiatives, the Company's growth and profitability prospects, the benefits of the Company's products to be realised by customers, the Company's position in the market and future opportunities therein, the deployment of Livelink and our other products by customers, and future performance of Open Text Corporation. Forward-looking statements may also include, without limitation, any statement relating to future events, conditions or circumstances. Forward-looking statements in this release are not promises or guarantees and are subject to certain risks and uncertainties, and actual results may differ materially. These risks and uncertainties include, among others, risks involved in the completion and integration of acquisitions, the possibility of technical, logistical or planning issues in connection with deployments, the continuous commitment of the Company's customers and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission (SEC), including the Form 10-K for the year ended June 30, 2004. You should not place undue reliance upon any such forward-looking statements, which are based on management's beliefs and opinions at the time the statements are made, and the Company does not undertake any obligations to update forward-looking statements should circumstances or management's beliefs or opinions change.

Copyright (C) 2005 by Open Text Corporation. LIVELINK and OPEN TEXT are trademarks or registered trademarks of Open Text Corporation in the United States of America, Canada, the European Union and/or other countries. This list of trademarks is not exhaustive. Other trademarks, registered trademarks, product names, company names, brands and service names mentioned herein are property of Open Text Corporation or other respective owners.

Contact Information

  • Open Text Corporation
    Margaret Dobbin
    Director, Industry Analyst Relations
    (519) 888-7111 ext.2410
    Open Text Corporation
    Richard Maganini
    Director, Corporate Communications
    (847) 267-9330 ext.4266